Summary
The purpose of this study was to investigate whether young insulin-dependent diabetic patients still develop peripheral nerve dysfunction when using modern multiple insulin injection therapy and to elucidate if this correlated with various disease parameters. Seventy-five patients, 7 to 20 years old with a duration of diabetes of more than 3 years, and 128 age-matched healthy control subjects underwent bilateral studies of median, peroneal, and sural nerves. Presence of diabetes lowered motor conduction velocity (p<0.0001), sensory conduction velocity (p<0.0001) and sensory nerve action potential (p<0.05) in all examined nerves. The mean change in conduction velocity induced by diabetes was −4.8 m/s in the peroneal nerve, −3.3 m/s in the median motor nerve, −2.6 m/s in the sural nerve and −2.4 m/s in the median sensory nerve. Fifty-seven percent of the patients had abnormal conduction (values outside 95% predictive interval) which was seen most often in the motor nerves, especially in the peroneal nerve (41%) followed by the median nerve (24%). In multiple regression analysis, long-term poor metabolic control and increased body length correlated with nerve dysfunction identified in most examined parameters. Three patients had signs or symptoms suggestive of neuropathy. It is concluded that despite modern multiple insulin injection therapy, with reasonably good metabolic control, nerve dysfunction is still common in children and adolescents with insulin-dependent diabetes mellitus. Risk factors are increased height and long-term poor metabolic control.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- MIT:
-
multiple insulin injection therapy
- MCV:
-
motor nerve conduction velocity
- CMAP:
-
compound muscle action potential
- DML:
-
distal motor latency
- SCV:
-
sensory nerve conduction velocity
- SNAP:
-
sensory nerve action potential
References
Dyck PJ, Kratz KM, Karnes JL et al. (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology 43: 817–824
Pirart J (1978) Diabetes mellitus and its degenerative complications. a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188
Orchard TJ, Dorman JS, Maser RE et al. (1990) Prevalence of complications in IDDM by sex and duration. Diabetes 39: 1116–1124
Young MJ, Boulton AJM, MacLeod AF, Williams DRR, Sonksen PH (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36: 150–154
Thomas PK, Tomlinson DR (1993) Diabetic and hypoglycaemic neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy, vol 2 (3rd edn). Saunders, Philadelphia London Toronto Montreal Sydney Tokyo, pp 1219–1250
Schaumburg HH, Spencer PS, Thomas PK (1983) Disorders of peripheral nerves. Contemporary Neurology Series no 24, FA Davis Company, Philadelphia, pp 41–55
Abraham R, Levy D (1990) Diabetic neuropathy: measurement and quantification. In: Ward J, Goto Y (eds) Diabetic neuropathy. Wiley, Chichester New York Brisbane Toronto Singapore, pp 259–268
Claus D, Mustafa C, Vogel W, Herz M, Neundörfer B (1993) Assessment of diabetic neuropathy: definition of norm and discrimination of abnormal nerve function. Muscle Nerve 16: 757–768
Lawrence DG, Locke S (1963) Neuropathy in children with diabetes mellitus. BMJ 1: 784–785
Gamstorp I, Shelburne SA, Engleson G, Redondo D, Traisman HS (1966) Peripheral neuropathy in juvenile diabetes. Diabetes 15: 411–418
Eeg-Olofsson O, Petersen I (1966) Childhood diabetic neuropathy a clinical and electrophysiological study. Acta Paediatrica 55: 163–176
Marcus J, Ehrlich R, Kelly M, Murphy EG (1973) Nerve conduction in childhood diabetes. Can Med Assoc J 108: 1116–1119
Ludvigsson J, Johannesson G, Heding L, HÄger A, Larsson Y (1979) Sensory nerve conduction velocity and vibratory sensibility in juvenile diabetics. Relationships to endogenous insulin. Acta Paediatrica 68: 739–743
Young RJ, Ewing DJ, Clarke BF (1983) Nerve function and metabolic control in teenage diabetics. Diabetes 32: 142–147
Hoffman WH, Hart ZH, Frank RN (1983) Correlates of delayed motor nerve conduction and retinopathy in juvenile-onset diabetes mellitus. J Pediatr 102: 351–356
KÄr ML, Saukkonen AL, PitkÄnen M, åkerblom HK (1983) Peripheral neuropathy in diabetic children and adolescents. A cross-sectional study. Acta Paediatrica 72: 373–378
Dorchy H, Noel P, Kruger M et al. (1985) Peroneal motor nerve conduction velocity in diabetic children and adolescents. Eur J Pediatr 144: 310–315
Young RJ, Macintyre CCA, Martyn CN et al. (1986) Progression of subclinical polyneuropathy in young patients with type 1 (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications). Diabetologia 29: 156–161
Kruger M, Brunko E, Dorchy H, NoËl P (1987) Femoral versus peroneal neuropathy in diabetic children and adolescents — relationships to clinical status, metabolic control and retinopathy. Diabete Metab 13: 110–115
Gallai V, Firenze C, Mazzotta G, Del Gatto F (1988) Neuropathy in children and adolescents with diabetes mellitus. Acta Neurol Scand 78: 136–140
Duck SC, Wei F, Parke J, Swick HM (1991) Role of height and glycosylated haemoglobin in abnormal nerve conduction in paediatric patients with type I diabetes mellitus after 4–9 yr of disease. Diabetes Care 14: 386–392
Allen C, Duck SC, Sufit RL, Swick HM, D'Alessio DJ (1992) Glycaemic control and peripheral nerve conduction in children and young adults after 5–6 months of IDDM. Diabetes Care 15: 502–507
Amthor K-F, Dahl-JØrgensen K, Berg TJ et al. (1994) The effect of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo study. Diabetologia 37: 579–584
Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J (1994) Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330: 15–18
The Diabetes Control and Complications Trial Research Group (1994) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
Reichard P, Nilsson B-Y, Rosenqvist U (1994) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304–309
Kullberg CE, Arnqvist HJ (1993) Elevated long-term glycated haemoglobin precedes proliferative retinopathy and nephropathy in type 1 (insulin-dependent) diabetic patients. Diabetologia 36: 961–965
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Johansson B-L (1992) Physiological effects of C-peptide administration in patients with type 1 diabetes. Thesis, Karolinska Institute, Stockholm
Grubin CE, Daniels T, Toivola B et al. (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37: 344–350
Ludin HP (1980) Electromyography in practice. Thieme, Stuttgart
Dyck PJ, Karnes J, O'Brien PC, Swanson CJ (1986) Neuropathy symptom profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology 36: 1300–1308
Lamontagne A, Buchtal F (1970) Electrophysiological studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 33: 442–452
Dyck PJ, Karnes JL, Daube J, O'Brien P, Service FJ (1985) Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 108: 861–880
Buchtal F, Rosenfalck A (1971) Sensory potentials in polyneuropathy. Brain 94: 241–262
Gregersen G (1967) Diabetic neuropathy: influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity. Neurology 17: 972–980
Ziegler D, Mayer P, Mühlen H, Gries FA (1991) The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34: 822–829
Pietri A, Ehle AL, Raskin P (1980) Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pump. Diabetes 29: 668–671
White NH, Waltman SR, Krupin T, Santiago JV (1981) Reversal of neuropathic and gastrointestinal complications related to diabetes mellitus in adolescents with improved metabolic control. J Pediatr 99: 41–45
Service FJ, Rizza RA, Daube JR, O'Brien PC, Dyck PJ (1985) Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia 28: 722–727
The Diabetes Control and Complications Trial Research Group (1988) Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of diabetes control and complication trial (DCCT). Diabetes 37: 476–481
Sosenko JM, Gadia MT, Fournier AM, O'Connell MT, Aguiar MC, Skyler JS (1986) Body stature as a risk factor for diabetic sensory neuropathy. Am J Med 80: 1031–1034
Gadia MT, Natori N, Ramos LB, Ayyar DR, Skyler JS, Sosenko JM (1987) Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy. Diabetes Care 10: 613–616
Robinson LR, Stolow WC, Rubner DE, Wahl PW, Leonetti DL, Fujimoto WY (1992) Height is an independent risk factor for neuropathy in diabetic men. Diabetes Res Clin Pract 16: 97–102
Sabin TD, Geschwind N, Waxman SG (1978) Patterns of clinical deficits in peripheral nerve disease. In: Waxman SG (ed) Physiology and pathobiology of axons. Raven Press, New York, pp 431–438
NoËl P (1973) Sensory nerve conduction in the upper limbs at various stages of diabetic neuropathy. J Neurol Neuro Psychiatry 36: 786–796
Kimura J, Yamada T, Stevland NP (1979) Distal slowing of motor nerve conduction velocity in diabetic polyneuropathy. J Neurol Sci 42: 291–302
Jakobsen J, Sidenius P (1980) Decreased axonal transport of structural proteins in streptozotocin diabetic rats. J Clin Invest 66: 292–297
Tuomi T, Zimmet PZ, Rowley MJ, Serjeantson SW, Mackay IR (1993) Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy. Diabetologia 36: 685 (Letter)
Sundkvist G, Velloso LA, KÄmpe O et al. (1994) Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients. Diabetologia 37: 293–299
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hyllienmark, L., Brismar, T. & Ludvigsson, J. Subclinical nerve dysfunction in children and adolescents with IDDM. Diabetologia 38, 685–692 (1995). https://doi.org/10.1007/BF00401840
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401840